{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T12:13:38Z","timestamp":1785932018762,"version":"3.56.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijoms.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Oral and Maxillofacial Surgery"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.ijom.2023.06.001","type":"journal-article","created":{"date-parts":[[2023,6,19]],"date-time":"2023-06-19T07:37:42Z","timestamp":1687160262000},"page":"122-126","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Utility of BRAF V600E immunohistochemistry in the diagnosis of mandibular ameloblastomas"],"prefix":"10.1016","volume":"53","author":[{"given":"Y.D.","family":"Ji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.N.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.C.","family":"Faquin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.S.","family":"Peacock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijom.2023.06.001_bib1","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/ng.2986","article-title":"Identification of recurrent SMO and BRAF mutations in ameloblastomas","volume":"46","author":"Sweeney","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.ijom.2023.06.001_bib2","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.oooo.2016.12.009","article-title":"Cost and lack of insurance coverage are prohibitive to having dental implants after resections for benign mandibular neoplasms","volume":"123","author":"Peacock","year":"2017","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"10.1016\/j.ijom.2023.06.001_bib3","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/path.4317","article-title":"High frequency of BRAF V600E mutations in ameloblastoma","volume":"232","author":"Kurppa","year":"2014","journal-title":"J Pathol"},{"key":"10.1016\/j.ijom.2023.06.001_bib4","unstructured":"Roche Diagnostics. Roche receives FDA clearance for the VENTANA MMR IHC Panel for patients diagnosed with colorectal cancer. \u3008https:\/\/diagnostics.roche.com\/es\/es\/news-listing\/2017\/roche-receives-fda-clearance-for-the-ventana-mmr-ihc-panel-for-p1.html\u3009, [Accessibility verified June 1, 2023]."},{"key":"10.1016\/j.ijom.2023.06.001_bib5","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1007\/s00405-015-3631-8","article-title":"Ameloblastoma: a clinical review and trends in management","volume":"273","author":"McClary","year":"2016","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.ijom.2023.06.001_bib6","first-page":"109","article-title":"Durable treatment of ameloblastoma with single agent BRAFi Re: clinical and radiographic response with combined BRAF-targeted therapy in stage 4 ameloblastoma","author":"Faden","year":"2017","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijom.2023.06.001_bib7","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.joms.2016.11.016","article-title":"What is important for confirming negative margins when resecting mandibular ameloblastomas?","volume":"75","author":"Peacock","year":"2017","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.ijom.2023.06.001_bib8","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1038\/s41379-022-01105-8","article-title":"The diagnostic utility of BRAF VE1 mutation-specific immunohistochemistry in ameloblastoma","volume":"35","author":"Mendez","year":"2022","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ijom.2023.06.001_bib9","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/jop.12671","article-title":"Absence of BRAFV600E mutation in odontogenic keratocysts","volume":"47","author":"Fran\u00e7a","year":"2018","journal-title":"J Oral Pathol Med"},{"key":"10.1016\/j.ijom.2023.06.001_bib10","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.oraloncology.2017.09.016","article-title":"Frequent oncogenic BRAF V600E mutation in odontogenic keratocyst","volume":"74","author":"Cha","year":"2017","journal-title":"Oral Oncol"},{"key":"10.1016\/j.ijom.2023.06.001_bib11","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1111\/jop.13081","article-title":"Absence of BRAFV600E immunohistochemical expression in sporadic odontogenic keratocyst, syndromic odontogenic keratocyst and orthokeratinized odontogenic cyst","volume":"49","author":"Jain","year":"2020","journal-title":"J Oral Pathol Med"},{"key":"10.1016\/j.ijom.2023.06.001_bib12","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.oooo.2019.04.001","article-title":"The BRAF p.V600E mutation is a common event in ameloblastomas but is absent in odontogenic keratocysts","volume":"129","author":"Zhang","year":"2020","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"10.1016\/j.ijom.2023.06.001_bib13","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.ijom.2004.01.013","article-title":"PTC gene mutations and expression of SHH, PTC, SMO, and GLI-1 in odontogenic keratocysts","volume":"33","author":"Ohki","year":"2004","journal-title":"Int J Oral Maxillofac Surg"},{"key":"10.1016\/j.ijom.2023.06.001_bib14","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/s13256-019-2140-6","article-title":"Persistent response to vemurafenib in metastatic ameloblastoma with BRAF mutation: a case report","volume":"13","author":"Broudic-Guibert","year":"2019","journal-title":"J Med Case Rep"},{"key":"10.1016\/j.ijom.2023.06.001_bib15","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1093\/jnci\/dju378","article-title":"Clinical and radiographic response with combined BRAF-targeted therapy in stage 4 ameloblastoma","volume":"107","author":"Kaye","year":"2015","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijom.2023.06.001_bib16","unstructured":"Colevas AD. Dabrafenib and trametinib in treating patients with BRAF mutated ameloblastoma. NCT02367859. Clinicaltrials.gov. \u3008https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02367859?cond=ameloblastoma&rank=1\u3009, [Accessibility verified June 1, 2023]."},{"key":"10.1016\/j.ijom.2023.06.001_bib17","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s12032-023-01993-z","article-title":"BRAF inhibitors in BRAF V600E-mutated ameloblastoma: systematic review of rare cases in the literature","volume":"40","author":"Ebeling","year":"2023","journal-title":"Med Oncol"},{"key":"10.1016\/j.ijom.2023.06.001_bib18","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.3389\/fonc.2019.01204","article-title":"Enabling precision medicine for rare head and neck tumors: the example of BRAF\/MEK targeting in patients with metastatic ameloblastoma","volume":"9","author":"Brunet","year":"2019","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijom.2023.06.001_bib19","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000000161","article-title":"Leukocyte count restoration under dabrafenib treatment in a melanoma patient with vemurafenib-induced leukopenia: case report","volume":"93","author":"Orouji","year":"2014","journal-title":"Medicine"}],"container-title":["International Journal of Oral and Maxillofacial Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0901502723001364?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0901502723001364?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T12:39:20Z","timestamp":1760272760000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0901502723001364"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S0901502723001364"],"URL":"https:\/\/doi.org\/10.1016\/j.ijom.2023.06.001","relation":{},"ISSN":["0901-5027"],"issn-type":[{"value":"0901-5027","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Utility of BRAF V600E immunohistochemistry in the diagnosis of mandibular ameloblastomas","name":"articletitle","label":"Article Title"},{"value":"International Journal of Oral and Maxillofacial Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijom.2023.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 International Association of Oral and Maxillofacial Surgeons. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}